COGT
Cogent Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$30.01
+1.66%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 34.52x
- P/S forward
- 32.30x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 9.78x
- Price / sales
- —
- Price / cash flow
- -16.93x
Enterprise value
- Enterprise value
- $4.7B
- EV / sales
- —
- EV / EBITDA
- -12.69x
- EV / EBIT
- -12.14x
- Market cap
- $5.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026